Nodexon (Dexamethasone)

Dexamethasone binds to intracellular glucocorticoid receptors, forming a complex that moves into the cell nucleus. There it interacts with glucocorticoid response elements, modifying gene transcription to lower production of inflammatory cytokines, inhibit leukocyte migration, and suppress immune activation, resulting in anti‑inflammatory and immunosuppressive effects.

The dosage of Nodexon is individualized. A qualified prescriber determines the appropriate strength, frequency, and duration based on the patient’s diagnosis, severity of disease, age, weight, and other clinical factors. Patients should follow the prescribing information provided by their healthcare professional.

Safety data for dexamethasone in pregnancy are limited, and the drug is generally used only when the potential benefit justifies any risk to the fetus. Dexamethasone is excreted in breast milk; therefore, breastfeeding mothers should discuss potential infant exposure with their physician before using Nodexon.

To place an order, submit an enquiry on the Nodexon product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Nodexon (dexamethasone) is a high‑potency, long‑acting glucocorticoid, offering stronger anti‑inflammatory effects than lower‑potency agents such as prednisone. Its longer half‑life allows less frequent dosing, but it may also carry a higher risk of systemic side effects, making careful monitoring essential when compared with milder corticosteroids.

Nodexon should be stored at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture, heat, and direct sunlight. Do not refrigerate or freeze the product, as this could affect tablet integrity.

Nodexon is supplied as an oral tablet and is taken by mouth with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with water; it should not be crushed, chewed, or divided unless specifically instructed by a healthcare professional.

Serious risks include severe infections due to immunosuppression, adrenal suppression leading to withdrawal syndrome, osteoporosis with long‑term use, hyperglycemia that may precipitate diabetic complications, and psychiatric effects such as psychosis. Patients should be monitored regularly for these potential complications.

Nodexon is contraindicated in patients with systemic fungal infections, known hypersensitivity to dexamethasone or any tablet excipients, and in individuals with uncontrolled viral infections where immunosuppression could worsen disease. It should also be avoided in patients receiving live vaccines without appropriate clinical justification.